BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32630498)

  • 1. Low-Volume Nodal Metastasis in Endometrial Cancer: Risk Factors and Prognostic Significance.
    García Pineda V; Hernández Gutiérrez A; Gracia Segovia M; Siegrist Ridruejo J; Diestro Tejeda MD; Zapardiel I
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32630498
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.
    St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM
    Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Volume Metastases in Apparent Early-Stage Endometrial Cancer: Prevalence, Clinical Significance, and Future Perspectives.
    Fumagalli D; De Vitis LA; Caruso G; Occhiali T; Palmieri E; Guillot BE; Pappalettera G; Langstraat CL; Glaser GE; Reynolds EA; Fruscio R; Landoni F; Mariani A; Grassi T
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risk of Recurrence in Endometrial Cancer Patients with Low-Volume Metastasis in the Sentinel Lymph Nodes: A Retrospective Multi-Institutional Study.
    Buda A; Paniga C; Taskin S; Mueller M; Zapardiel I; Fanfani F; Puppo A; Casarin J; Papadia A; De Ponti E; Grassi T; Mauro J; Turan H; Vatansever D; Gungor M; Ortag F; Imboden S; Garcia-Pineda V; Mohr S; Siegenthaler F; Perotto S; Landoni F; Ghezzi F; Scambia G; Taskiran C; Fruscio R
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?
    Nica A; Gien LT; Ferguson SE; Covens A
    Int J Gynecol Cancer; 2020 Mar; 30(3):285-290. PubMed ID: 31871114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells.
    Bogani G; Mariani A; Paolini B; Ditto A; Raspagliesi F
    Gynecol Oncol; 2019 Jun; 153(3):670-675. PubMed ID: 30833134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer.
    Cibula D; Abu-Rustum NR; Dusek L; Zikán M; Zaal A; Sevcik L; Kenter GG; Querleu D; Jach R; Bats AS; Dyduch G; Graf P; Klat J; Lacheta J; Meijer CJ; Mery E; Verheijen R; Zweemer RP
    Gynecol Oncol; 2012 Mar; 124(3):496-501. PubMed ID: 22120175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-volume metastatic nodal disease in endometrial cancer.
    Hambálek J; Maděrka M; Kolečková M; Pilka R
    Ceska Gynekol; 2019; 84(6):458-462. PubMed ID: 31948256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer.
    Jo MJ; Park JY; Song JS; Kook MC; Ryu KW; Cho SJ; Lee JH; Nam BH; Hong EK; Choi IJ; Kim YW
    World J Gastroenterol; 2015 Jan; 21(2):667-74. PubMed ID: 25593497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-operative assessment of sentinel lymph node status by one-step nucleic acid amplification assay (OSNA) in early endometrial cancer: a prospective study.
    Monterossi G; Buca D; Dinoi G; La Fera E; Zannoni GF; Spadola S; Scambia G; Fanfani F
    Int J Gynecol Cancer; 2019 Jul; 29(6):1016-1020. PubMed ID: 31175137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison.
    Fanfani F; Monterossi G; Di Meo ML; La Fera E; Dell'Orto F; Gioè A; Lamanna M; Ferrari D; De Ponti E; Perego P; Restaino S; Carlo R; Zannoni GF; Landoni F; Scambia G; Buda A
    Int J Gynecol Cancer; 2020 Mar; 30(3):372-377. PubMed ID: 31996396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.